Blood Cancer Journal
Издатель: Springer Nature · 8 статей
-
Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era
Blood Cancer Journal, Published online: 17 November 2026; doi:10.1038/s41408-026-01670-0 Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era
-
Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)
Blood Cancer Journal, Published online: 16 November 2026; doi:10.1038/s41408-026-01674-w Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to...
-
Implications of TP53 mutations in patients with higher risk myelodysplastic syndromes (MDS) who received hypomethylating agent therapy: an analysis from the VALIDATE database of the International Consortium for MDS
Blood Cancer Journal, Published online: 14 November 2026; doi:10.1038/s41408-026-01584-x Implications of TP53 mutations in patients with higher risk myelodysplastic syndromes (MDS) who received hypomethylating agent therapy: an analysis...
-
Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma
Blood Cancer Journal, Published online: 13 November 2026; doi:10.1038/s41408-026-01676-8 Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma
-
Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)
Blood Cancer Journal, Published online: 11 November 2026; doi:10.1038/s41408-026-01641-5 Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)
-
Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies
Blood Cancer Journal, Published online: 09 November 2026; doi:10.1038/s41408-026-01660-2 Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and...
-
Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study
Blood Cancer Journal, Published online: 05 November 2026; doi:10.1038/s41408-026-01642-4 Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study
-
CAPA induction followed by sequential radiotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma: a multicentre, single-arm, phase 2 trial
Blood Cancer Journal, Published online: 03 November 2026; doi:10.1038/s41408-026-01623-7 CAPA induction followed by sequential radiotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma: a multicentre, single-arm, phase 2 trial